|
US5989463A
(en)
*
|
1997-09-24 |
1999-11-23 |
Alkermes Controlled Therapeutics, Inc. |
Methods for fabricating polymer-based controlled release devices
|
|
US6013258A
(en)
*
|
1997-10-09 |
2000-01-11 |
Zycos Inc. |
Immunogenic peptides from the HPV E7 protein
|
|
US6183746B1
(en)
|
1997-10-09 |
2001-02-06 |
Zycos Inc. |
Immunogenic peptides from the HPV E7 protein
|
|
WO2000013666A1
(en)
*
|
1998-09-05 |
2000-03-16 |
Seung Jin Lee |
Biodegradable particulate polymeric preparation and process for producing thereof
|
|
KR20000022894A
(ko)
*
|
1998-09-05 |
2000-04-25 |
이승진 |
생분해성 고분자 미립자형 제제 및 그 제조방법
|
|
DE19848849A1
(de)
*
|
1998-10-22 |
2000-04-27 |
Knoll Ag |
Verfahren zur Herstellung von festen, sphärischen Formen, enthaltend eine biologisch aktive Substanz
|
|
EP1058539A1
(en)
*
|
1999-01-06 |
2000-12-13 |
Korea Research Institute Of Chemical Technology |
Method of preparing pharmaceutical active ingredient comprising water-insoluble drug and pharmaceutical composition for oral administration comprising the same
|
|
US6159491A
(en)
*
|
1999-02-12 |
2000-12-12 |
Biovector Technologies, Inc. |
Prolonged release bioadhesive vaginal gel dosage form
|
|
KR100372751B1
(ko)
*
|
1999-11-16 |
2003-02-17 |
한국과학기술원 |
생체조직공학용 다공성 생분해성 고분자 지지체의 제조방법
|
|
ES2261195T3
(es)
*
|
1999-04-05 |
2006-11-16 |
Mannkind Corporation |
Metodo de formacion de particulas finas.
|
|
AU3957400A
(en)
|
1999-04-16 |
2000-11-02 |
Novo Nordisk A/S |
Dry, mouldable drug formulation
|
|
US7759113B2
(en)
*
|
1999-04-30 |
2010-07-20 |
The General Hospital Corporation |
Fabrication of tissue lamina using microfabricated two-dimensional molds
|
|
ATE288478T1
(de)
*
|
1999-04-30 |
2005-02-15 |
Massachusetts Gen Hospital |
Herstellung von dreidimensionalem vaskularisierten gewebe mittels der verwendung von zweidimensionalen mikrohergestellten formen
|
|
US7371400B2
(en)
|
2001-01-02 |
2008-05-13 |
The General Hospital Corporation |
Multilayer device for tissue engineering
|
|
US6291013B1
(en)
|
1999-05-03 |
2001-09-18 |
Southern Biosystems, Inc. |
Emulsion-based processes for making microparticles
|
|
US6444223B1
(en)
*
|
1999-05-28 |
2002-09-03 |
Alkermes Controlled Therapeutics, Inc. |
Method of producing submicron particles of a labile agent and use thereof
|
|
HUP0201626A3
(en)
*
|
1999-06-04 |
2004-05-28 |
Alza Corp Mountain View |
Implantable gel compositions and method of manufacture
|
|
US9006175B2
(en)
|
1999-06-29 |
2015-04-14 |
Mannkind Corporation |
Potentiation of glucose elimination
|
|
EP1074248A1
(en)
*
|
1999-07-08 |
2001-02-07 |
Arnold Hilgers |
Delivery system for biological material
|
|
US8106098B2
(en)
*
|
1999-08-09 |
2012-01-31 |
The General Hospital Corporation |
Protein conjugates with a water-soluble biocompatible, biodegradable polymer
|
|
US6822086B1
(en)
*
|
1999-08-09 |
2004-11-23 |
The General Hospital Corporation |
Drug-carrier complexes and methods of use thereof
|
|
AU6536400A
(en)
*
|
1999-08-11 |
2001-03-05 |
Alkermes Controlled Therapeutics, Inc. |
Method of delivering a chemotherapeutic agent to a solid tumor
|
|
US6284283B1
(en)
|
1999-10-21 |
2001-09-04 |
Alkermes Controlled Therapeutics, Inc. |
Method of producing sub-micron particles of biologically active agents and uses thereof
|
|
AU1226901A
(en)
*
|
1999-10-22 |
2001-05-08 |
Amgen, Inc. |
Biodegradable microparticles with novel erythropoietin stimulating protein
|
|
WO2001047572A2
(en)
*
|
1999-12-29 |
2001-07-05 |
Advanced Cardiovascular Systems, Inc. |
Device and active component for inhibiting formation of thrombus-inflammatory cell matrix
|
|
US7029700B2
(en)
*
|
2000-01-14 |
2006-04-18 |
Brown University Research Foundation |
Micronized freeze-dried particles
|
|
WO2001052818A1
(en)
|
2000-01-19 |
2001-07-26 |
Pharmaceutical Discovery Corporation |
Dry powder formulations of antihistamine for nasal administration
|
|
US6551838B2
(en)
*
|
2000-03-02 |
2003-04-22 |
Microchips, Inc. |
Microfabricated devices for the storage and selective exposure of chemicals and devices
|
|
US7074803B2
(en)
*
|
2001-03-02 |
2006-07-11 |
Durect Corporation |
Opioid formulations
|
|
WO2001076650A1
(en)
|
2000-04-06 |
2001-10-18 |
University Technology Corporation |
Compositions and methods for promoting wound healing
|
|
US7776021B2
(en)
|
2000-04-28 |
2010-08-17 |
The Charles Stark Draper Laboratory |
Micromachined bilayer unit for filtration of small molecules
|
|
EP1313425B1
(en)
*
|
2000-07-14 |
2007-03-07 |
Novo Nordisk A/S |
Method of moulding a pharmaceutical composition in a packaging material
|
|
US6362308B1
(en)
*
|
2000-08-10 |
2002-03-26 |
Alkermes Controlled Therapeutics Inc. Ii |
Acid end group poly(d,l-lactide-co-glycolide) copolymers high glycolide content
|
|
KR100867392B1
(ko)
*
|
2000-08-15 |
2008-11-06 |
더 보드 오브 트러스티즈 오브 더 유니버시티 오브 일리노이 |
마이크로입자
|
|
US6565888B1
(en)
|
2000-08-23 |
2003-05-20 |
Alkermes Controlled Therapeutics, Inc. |
Methods and compositions for the targeted delivery of biologically active agents
|
|
CA2420854C
(en)
*
|
2000-09-01 |
2013-07-30 |
Palmaya Pty Ltd |
Slow release pharmaceutical preparation and method of administering of same
|
|
US7666445B2
(en)
|
2000-10-20 |
2010-02-23 |
The Trustees Of The University Of Pennsylvania |
Polymer-based surgically implantable haloperidol delivery systems and methods for their production and use
|
|
AU3941002A
(en)
|
2000-10-31 |
2002-06-03 |
Zycos Inc |
Cyp1b1 nucleic acids and methods of use
|
|
EP1365770A2
(en)
*
|
2001-02-07 |
2003-12-03 |
Durect Corporation |
Devices and methods for management of bone density
|
|
SK14182003A3
(sk)
*
|
2001-05-23 |
2004-05-04 |
Hexal Ag |
Homogenizát pre implantáty a mikročastice
|
|
US6730772B2
(en)
|
2001-06-22 |
2004-05-04 |
Venkatram P. Shastri |
Degradable polymers from derivatized ring-opened epoxides
|
|
CN1307259C
(zh)
*
|
2001-08-03 |
2007-03-28 |
东丽株式会社 |
树脂组合物和由该树脂组合物制成的成型制品、薄膜和纤维
|
|
US7687053B2
(en)
|
2001-08-20 |
2010-03-30 |
Boston Scientific Scimed, Inc. |
Embolic compositions with non-cyanoacrylate rheology modifying agents
|
|
US8454997B2
(en)
|
2001-12-18 |
2013-06-04 |
Novo Nordisk A/S |
Solid dose micro implant
|
|
US7190781B2
(en)
*
|
2002-01-04 |
2007-03-13 |
Telefonaktiebolaget Lm Ericsson (Publ) |
Message transfer part point code mapping method and node
|
|
WO2003059988A2
(en)
*
|
2002-01-14 |
2003-07-24 |
The General Hospital Corporation |
Biodegradable polyketal polymers and methods for their formation and use
|
|
WO2003070905A2
(en)
*
|
2002-02-15 |
2003-08-28 |
Zycos, Inc. |
Electroporation methods for introducing bioactive agents into cells
|
|
US8728510B1
(en)
|
2002-03-15 |
2014-05-20 |
Advanced Cardiovascular Systems, Inc. |
Biocompatible carrier containing a bioadhesive material
|
|
WO2003080149A2
(en)
|
2002-03-20 |
2003-10-02 |
Mannkind Corporation |
Inhalation apparatus
|
|
US7776314B2
(en)
|
2002-06-17 |
2010-08-17 |
Grunenthal Gmbh |
Abuse-proofed dosage system
|
|
CA2492803C
(en)
|
2002-07-19 |
2013-11-05 |
The General Hospital Corporation |
Oxime conjugates and methods for their formation and use
|
|
GB2399084B
(en)
*
|
2002-07-30 |
2007-01-31 |
Univ Liverpool |
Porous beads and method of production thereof
|
|
GB0222522D0
(en)
|
2002-09-27 |
2002-11-06 |
Controlled Therapeutics Sct |
Water-swellable polymers
|
|
CA2500065A1
(en)
*
|
2002-09-30 |
2004-04-15 |
Acusphere, Inc. |
Sustained release porous microparticles for inhalation
|
|
US6800663B2
(en)
*
|
2002-10-18 |
2004-10-05 |
Alkermes Controlled Therapeutics Inc. Ii, |
Crosslinked hydrogel copolymers
|
|
DE602004022508D1
(de)
|
2003-01-16 |
2009-09-24 |
Gen Hospital Corp |
Verwendung von dreidimensionalen, mikrogefertigten, mittels gewebetechnologie hergestellten systemen für pharmakologische anwendungen
|
|
WO2004064752A2
(en)
*
|
2003-01-22 |
2004-08-05 |
Alkermes Controlled Therapeutics, Inc. |
Method of preparing sustained release microparticles
|
|
DE10303584A1
(de)
*
|
2003-01-30 |
2004-08-12 |
Stauss, Robert, Dr. |
Verwendung von Erythropoietin (EPO) als ein Beschichtungsmaterial auf medizinischen Implantaten
|
|
US7736391B2
(en)
|
2003-02-06 |
2010-06-15 |
Tonaba Healthscience Ii, Llc |
Cosmetic and reconstructive prostheses with a microencapsulated biologically compatible rupture indicator for sustained release and methods of detecting compromise of a prosthesis
|
|
WO2004084819A2
(en)
*
|
2003-03-19 |
2004-10-07 |
University Of Kentucky Research Foundation |
Poly(acryloyl-hydroxyethyl starch)-plga composite microspheres
|
|
US7051485B2
(en)
*
|
2003-04-29 |
2006-05-30 |
Greg Burnette |
Ceiling panel system
|
|
EP1636351A4
(en)
|
2003-05-21 |
2007-04-04 |
Gen Hospital Corp |
MICROFABRICATED COMPOSITIONS AND METHODS OF TISSUE GENIUS FOR OBTAINING TISSUES CONTAINING MULTIPLE CELLULAR TYPES
|
|
DE10361596A1
(de)
|
2003-12-24 |
2005-09-29 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
|
|
DE10336400A1
(de)
|
2003-08-06 |
2005-03-24 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte Darreichungsform
|
|
DE102005005446A1
(de)
|
2005-02-04 |
2006-08-10 |
Grünenthal GmbH |
Bruchfeste Darreichungsformen mit retardierter Freisetzung
|
|
US20070048228A1
(en)
|
2003-08-06 |
2007-03-01 |
Elisabeth Arkenau-Maric |
Abuse-proofed dosage form
|
|
ATE507845T1
(de)
*
|
2003-09-05 |
2011-05-15 |
Gen Hospital Corp |
Polyacetal-arzneimittelkonjugate als freisetzungssystem
|
|
BRPI0414907A
(pt)
*
|
2003-09-30 |
2006-11-07 |
Acusphere Inc |
formulações farmacêuticas com liberação sustentada injetáveis, orais ou tópicas
|
|
JP2007507527A
(ja)
*
|
2003-09-30 |
2007-03-29 |
スフェリックス， インコーポレイテッド |
生物学的に活性なナノ粒子治療用因子
|
|
US7309500B2
(en)
*
|
2003-12-04 |
2007-12-18 |
The Board Of Trustees Of The University Of Illinois |
Microparticles
|
|
RU2542391C2
(ru)
*
|
2003-12-30 |
2015-02-20 |
Аугустинус БАДЕР |
Способ регенерации ткани
|
|
US8329203B2
(en)
*
|
2004-01-12 |
2012-12-11 |
The Trustees Of The University Of Pennsylvania |
Drug-containing implants and methods of use thereof
|
|
US8221778B2
(en)
|
2005-01-12 |
2012-07-17 |
The Trustees Of The University Of Pennsylvania |
Drug-containing implants and methods of use thereof
|
|
EP2633853A1
(en)
*
|
2004-01-12 |
2013-09-04 |
The Trustees of The University of Pennsylvania |
Long-term delivery formulations and methods of use thereof
|
|
WO2005072702A2
(en)
*
|
2004-01-20 |
2005-08-11 |
Alkermes Controlled Therapeutics, Inc. |
Method for milling frozen microparticles
|
|
US20050188921A1
(en)
*
|
2004-02-27 |
2005-09-01 |
Anthony Malone |
Matrix assisted pulsed-laser evaporation technique for coating a medical device and associated system and medical device
|
|
ATE413398T1
(de)
*
|
2004-04-08 |
2008-11-15 |
Wyeth Corp |
Thioamidderivate als progesteronrezeptormodulatoren
|
|
WO2005104711A2
(en)
*
|
2004-04-27 |
2005-11-10 |
Wyeth |
Purification of progesterone receptor modulators
|
|
WO2005110369A2
(en)
*
|
2004-04-30 |
2005-11-24 |
American Pharmaceutical Partners, Inc. |
Sustained-release microspheres and methods of making and using same
|
|
CA2570960C
(en)
*
|
2004-06-17 |
2013-10-01 |
Valera Pharmaceuticals, Inc. |
Compositions and methods for treating central precocious puberty
|
|
DE102004032049A1
(de)
|
2004-07-01 |
2006-01-19 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte, orale Darreichungsform
|
|
EP1781264B1
(en)
|
2004-08-04 |
2013-07-24 |
Evonik Corporation |
Methods for manufacturing delivery devices and devices thereof
|
|
GB0417401D0
(en)
|
2004-08-05 |
2004-09-08 |
Controlled Therapeutics Sct |
Stabilised prostaglandin composition
|
|
ATE486064T1
(de)
|
2004-08-20 |
2010-11-15 |
Mannkind Corp |
Katalyse der diketopiperazinsynthese
|
|
HUE025151T2
(en)
|
2004-08-23 |
2016-01-28 |
Mannkind Corp |
Diceto-piperazine salts for drug delivery
|
|
US8367099B2
(en)
|
2004-09-28 |
2013-02-05 |
Atrium Medical Corporation |
Perforated fatty acid films
|
|
WO2006036982A2
(en)
|
2004-09-28 |
2006-04-06 |
Atrium Medical Corporation |
Drug delivery coating for use with a stent
|
|
US9801982B2
(en)
|
2004-09-28 |
2017-10-31 |
Atrium Medical Corporation |
Implantable barrier device
|
|
US9000040B2
(en)
|
2004-09-28 |
2015-04-07 |
Atrium Medical Corporation |
Cross-linked fatty acid-based biomaterials
|
|
US8312836B2
(en)
|
2004-09-28 |
2012-11-20 |
Atrium Medical Corporation |
Method and apparatus for application of a fresh coating on a medical device
|
|
EP1811933B1
(en)
|
2004-09-28 |
2016-03-23 |
Atrium Medical Corporation |
Barrier layer
|
|
US9012506B2
(en)
|
2004-09-28 |
2015-04-21 |
Atrium Medical Corporation |
Cross-linked fatty acid-based biomaterials
|
|
BRPI0516593A
(pt)
*
|
2004-10-14 |
2008-09-16 |
Tufts College |
polìmeros eletroquimicamente degradáveis
|
|
US7748343B2
(en)
|
2004-11-22 |
2010-07-06 |
The Board Of Trustees Of The University Of Illinois |
Electrohydrodynamic spraying system
|
|
US20080213593A1
(en)
*
|
2005-01-21 |
2008-09-04 |
President And Fellows Of Harvard College |
Systems And Methods For Forming Fluidic Droplets Encapsulated In Particles Such As Colloidal Particles
|
|
DE102005005449A1
(de)
|
2005-02-04 |
2006-08-10 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
|
|
US7759312B2
(en)
*
|
2005-03-11 |
2010-07-20 |
Endo Pharmaceuticals Solutions Inc. |
Delivery of dry formulations of octreotide
|
|
EP1888043A4
(en)
*
|
2005-03-11 |
2010-07-28 |
Endo Pharmaceuticals Solutions |
OCTREOTIDE FORMULATIONS WITH CONTROLLED RELEASE
|
|
KR101486397B1
(ko)
|
2005-09-14 |
2015-01-28 |
맨카인드 코포레이션 |
활성제에 대한 결정질 미립자 표면의 친화력의 증가를 기반으로 하는 약물 제제화의 방법
|
|
US9278161B2
(en)
|
2005-09-28 |
2016-03-08 |
Atrium Medical Corporation |
Tissue-separating fatty acid adhesion barrier
|
|
US9427423B2
(en)
|
2009-03-10 |
2016-08-30 |
Atrium Medical Corporation |
Fatty-acid based particles
|
|
WO2007047781A2
(en)
|
2005-10-15 |
2007-04-26 |
Atrium Medical Corporation |
Hydrophobic cross-linked gels for bioabsorbable drug carrier coatings
|
|
US7669732B2
(en)
*
|
2005-10-25 |
2010-03-02 |
Imi Cornelius Inc. |
Cup lid dispenser
|
|
KR20080096809A
(ko)
|
2006-02-22 |
2008-11-03 |
맨카인드 코포레이션 |
디케토피페라진 및 활성제를 포함하는 마이크로입자의 약학특성의 개선 방법
|
|
EP2012751A4
(en)
*
|
2006-03-21 |
2010-11-24 |
Morehouse School Of Medicine |
NEW NANOPARTICLES FOR THE DELIVERY OF ACTIVE AGENTS
|
|
US8747870B2
(en)
|
2006-04-20 |
2014-06-10 |
University Of Utah Research Foundation |
Polymeric compositions and methods of making and using thereof
|
|
CA2649915A1
(en)
*
|
2006-04-20 |
2007-11-01 |
University Of Utah Research Foundation |
Polymeric compositions and methods of making and using thereof
|
|
GB0613333D0
(en)
|
2006-07-05 |
2006-08-16 |
Controlled Therapeutics Sct |
Hydrophilic polyurethane compositions
|
|
GB0613638D0
(en)
|
2006-07-08 |
2006-08-16 |
Controlled Therapeutics Sct |
Polyurethane elastomers
|
|
US20080075777A1
(en)
*
|
2006-07-31 |
2008-03-27 |
Kennedy Michael T |
Apparatus and methods for preparing solid particles
|
|
ITMI20061545A1
(it)
*
|
2006-08-02 |
2008-02-03 |
Mediolanum Pharmaceuticals Ltd |
Particelle in grado di rilasciare il principio attivo per un periodo prolungato di tempo
|
|
ITMI20061538A1
(it)
*
|
2006-08-02 |
2008-02-03 |
Mediolanum Pharmaceuticals Ltd |
Impianti sottocutanei in grado di rilasciare il principio attivo per un periodo prolungato di tempo
|
|
GB0620685D0
(en)
|
2006-10-18 |
2006-11-29 |
Controlled Therapeutics Sct |
Bioresorbable polymers
|
|
US9492596B2
(en)
|
2006-11-06 |
2016-11-15 |
Atrium Medical Corporation |
Barrier layer with underlying medical device and one or more reinforcing support structures
|
|
EP2083875B1
(en)
|
2006-11-06 |
2013-03-27 |
Atrium Medical Corporation |
Coated surgical mesh
|
|
PE20090167A1
(es)
*
|
2007-03-09 |
2009-02-11 |
Wyeth Corp |
Sintesis y caracterizacion de la forma iii polimorfica de 4-(2-(4,4-dimetil-2-oxooxazolidin-3-il)tiazol-4-il)benzonitrilo
|
|
MX2009011641A
(es)
*
|
2007-04-27 |
2010-03-04 |
Endo Pharmaceuticals Solutions |
Agentes de liberacion para dispositivo de implante y metodos para utilizar los mismos.
|
|
CN101932308B
(zh)
|
2007-12-04 |
2014-11-05 |
治疗医药股份有限公司 |
改良的配制剂和用于冻干的方法及由此提供的冻干物
|
|
WO2009085952A1
(en)
|
2007-12-20 |
2009-07-09 |
Brookwood Pharmaceuticals, Inc. |
Process for preparing microparticles having a low residual solvent volume
|
|
JP5774853B2
(ja)
|
2008-01-25 |
2015-09-09 |
グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング |
医薬投薬形
|
|
MX2010012039A
(es)
*
|
2008-05-09 |
2010-11-30 |
Gruenenthal Gmbh |
Proceso para la preparacion de una formulacion de polvo intermedia y una forma de dosificacion solida final bajo el uso de un paso de congelacion por rocio.
|
|
US20090325964A1
(en)
*
|
2008-05-23 |
2009-12-31 |
Wyeth |
Piperazine Metabotropic Glutamate Receptor 5 (MGLUR5) Negative Allosteric Modulators For Anxiety/Depression
|
|
ES2929343T3
(es)
|
2008-06-13 |
2022-11-28 |
Mannkind Corp |
Inhalador de polvo seco accionado por aspiración para la administración de fármacos
|
|
US8485180B2
(en)
|
2008-06-13 |
2013-07-16 |
Mannkind Corporation |
Dry powder drug delivery system
|
|
MX2010014240A
(es)
|
2008-06-20 |
2011-03-25 |
Mankind Corp |
Un metodo y aparato interactivo para perfilar en tiempo real esfuerzos de inhalacion.
|
|
US8071537B2
(en)
*
|
2008-06-25 |
2011-12-06 |
Endo Pharmaceuticals Solutions Inc. |
Implantable device for the sustained release of a polypeptide
|
|
JP5536053B2
(ja)
*
|
2008-06-25 |
2014-07-02 |
エンド ファーマスーティカルズ ソリューションズ インコーポレイテッド． |
離型剤を有するオクトレオチドインプラント
|
|
TWI494123B
(zh)
|
2008-08-11 |
2015-08-01 |
Mannkind Corp |
超快起作用胰島素之用途
|
|
WO2010066203A1
(en)
*
|
2008-12-10 |
2010-06-17 |
Anhui Zhongren Technology Co., Ltd. |
Controlled releasing composition
|
|
CL2009002167A1
(es)
*
|
2008-12-10 |
2010-10-15 |
Mersana Therapeutics Inc |
Formulacion farmaceutica para administracion endovenosa que comprende un compuesto derivado de conjugados de camptotecina-polimero biocompatibles y biodegradables, un agente de estabilizacion, uno o varios tampones y un tensoactivo, util para el tratamiento del cancer.
|
|
US8314106B2
(en)
|
2008-12-29 |
2012-11-20 |
Mannkind Corporation |
Substituted diketopiperazine analogs for use as drug delivery agents
|
|
CA2749993C
(en)
*
|
2009-01-23 |
2016-12-20 |
Surmodics Pharmaceuticals, Inc. |
Continuous double emulsion process for making microparticles
|
|
WO2010105094A1
(en)
|
2009-03-11 |
2010-09-16 |
Mannkind Corporation |
Apparatus, system and method for measuring resistance of an inhaler
|
|
MY157166A
(en)
|
2009-06-12 |
2016-05-13 |
Mankind Corp |
Diketopiperazine microparticles with defined specific surface areas
|
|
BR112012001547A2
(pt)
|
2009-07-22 |
2016-03-08 |
Gruenenthal Gmbh |
forma de dosagem farmacêutica extrusada por fusão a quente
|
|
ES2428938T3
(es)
|
2009-07-22 |
2013-11-12 |
Grünenthal GmbH |
Forma de dosificación resistente a la manipulación y estabilizada frente a la oxidación
|
|
US20110038910A1
(en)
|
2009-08-11 |
2011-02-17 |
Atrium Medical Corporation |
Anti-infective antimicrobial-containing biomaterials
|
|
US8877746B2
(en)
*
|
2009-08-25 |
2014-11-04 |
Cardioklne, Inc |
Compositions for delivery of insoluble agents
|
|
EP2480200A2
(en)
*
|
2009-09-22 |
2012-08-01 |
Evonik Degussa Corporation |
Implant devices having varying bioactive agent loading configurations
|
|
WO2011056889A1
(en)
|
2009-11-03 |
2011-05-12 |
Mannkind Corporation |
An apparatus and method for simulating inhalation efforts
|
|
CN102821757B
(zh)
*
|
2010-02-03 |
2016-01-20 |
格吕伦塔尔有限公司 |
通过挤出机制备粉末状药物组合物
|
|
BR112012033060A2
(pt)
|
2010-06-21 |
2018-02-27 |
Mannkind Corp |
métodos de sistema de liberação de fármaco em pó seco
|
|
EP2593141B1
(en)
|
2010-07-16 |
2018-07-04 |
Atrium Medical Corporation |
Composition and methods for altering the rate of hydrolysis of cured oil-based materials
|
|
CN103179954A
(zh)
|
2010-09-02 |
2013-06-26 |
格吕伦塔尔有限公司 |
包含阴离子聚合物的抗破碎剂型
|
|
CA2808219C
(en)
|
2010-09-02 |
2019-05-14 |
Gruenenthal Gmbh |
Tamper resistant dosage form comprising inorganic salt
|
|
EP2673357A2
(en)
|
2011-02-07 |
2013-12-18 |
Life Technologies Corporation |
Compositions and methods for stabilizing susceptible compounds
|
|
AU2012236150B2
(en)
|
2011-04-01 |
2016-03-31 |
Mannkind Corporation |
Blister package for pharmaceutical cartridges
|
|
WO2012172449A1
(en)
|
2011-06-13 |
2012-12-20 |
Pfizer Inc. |
Lactams as beta secretase inhibitors
|
|
WO2012174472A1
(en)
|
2011-06-17 |
2012-12-20 |
Mannkind Corporation |
High capacity diketopiperazine microparticles
|
|
PL2736497T3
(pl)
|
2011-07-29 |
2018-01-31 |
Gruenenthal Gmbh |
Tabletka odporna na ingerencję, zapewniająca natychmiastowe uwalnianie leku
|
|
CA2839123A1
(en)
|
2011-07-29 |
2013-02-07 |
Grunenthal Gmbh |
Tamper-resistant tablet providing immediate drug release
|
|
EP2744483B1
(en)
*
|
2011-08-15 |
2020-04-29 |
Jyant Technologies |
Delivery system for specifically targeting cancer cells and method of use thereof
|
|
BR112014009686A2
(pt)
|
2011-10-24 |
2018-08-07 |
Mannkind Corp |
composição analgésica inalável, pó seco e método para tratar dor
|
|
WO2013087903A1
(en)
|
2011-12-16 |
2013-06-20 |
Dsm Ip Assets B.V. |
Process for the manufacturing of a drug delivery system based on a polymer comprising a dispersed bioactive agent
|
|
MX356421B
(es)
|
2012-02-28 |
2018-05-29 |
Gruenenthal Gmbh |
Forma de dosificacion resistente a la manipulacion indebida que comprende un compuesto farmacologicamente activo y un polimero anionico.
|
|
PL2838512T3
(pl)
|
2012-04-18 |
2018-12-31 |
Grünenthal GmbH |
Farmaceutyczna postać dawkowania odporna na niewłaściwe użycie i odporna na uderzeniowe uwalnianie dawki
|
|
US10064945B2
(en)
|
2012-05-11 |
2018-09-04 |
Gruenenthal Gmbh |
Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
|
|
US9867880B2
(en)
|
2012-06-13 |
2018-01-16 |
Atrium Medical Corporation |
Cured oil-hydrogel biomaterial compositions for controlled drug delivery
|
|
AU2013289957B2
(en)
|
2012-07-12 |
2017-02-23 |
Mannkind Corporation |
Dry powder drug delivery systems and methods
|
|
WO2014066856A1
(en)
|
2012-10-26 |
2014-05-01 |
Mannkind Corporation |
Inhalable influenza vaccine compositions and methods
|
|
KR102246914B1
(ko)
|
2013-03-15 |
2021-04-30 |
맨카인드 코포레이션 |
미세결정성 디케토피페라진 조성물 및 방법
|
|
MX371432B
(es)
|
2013-05-29 |
2020-01-30 |
Gruenenthal Gmbh |
Forma de dosificacion resistente al uso indebido que contiene una o mas particulas.
|
|
WO2014191396A1
(en)
|
2013-05-29 |
2014-12-04 |
Grünenthal GmbH |
Tamper resistant dosage form with bimodal release profile
|
|
US10624862B2
(en)
|
2013-07-12 |
2020-04-21 |
Grünenthal GmbH |
Tamper-resistant dosage form containing ethylene-vinyl acetate polymer
|
|
CN114848614A
(zh)
|
2013-07-18 |
2022-08-05 |
曼金德公司 |
热稳定性干粉药物组合物和方法
|
|
EP3030294B1
(en)
|
2013-08-05 |
2020-10-07 |
MannKind Corporation |
Insufflation apparatus
|
|
WO2015078891A1
(en)
|
2013-11-26 |
2015-06-04 |
Farmaceutici Formenti S.P.A. |
Preparation of a powdery pharmaceutical composition by means of cryo-milling
|
|
US10307464B2
(en)
|
2014-03-28 |
2019-06-04 |
Mannkind Corporation |
Use of ultrarapid acting insulin
|
|
US20150320690A1
(en)
|
2014-05-12 |
2015-11-12 |
Grünenthal GmbH |
Tamper resistant immediate release capsule formulation comprising tapentadol
|
|
EP3148512A1
(en)
|
2014-05-26 |
2017-04-05 |
Grünenthal GmbH |
Multiparticles safeguarded against ethanolic dose-dumping
|
|
US10561806B2
(en)
|
2014-10-02 |
2020-02-18 |
Mannkind Corporation |
Mouthpiece cover for an inhaler
|
|
BR112017021475A2
(pt)
|
2015-04-24 |
2018-07-10 |
Gruenenthal Gmbh |
forma de dosagem resistente à adulteração (tamper) com liberação imediata e resistência contra extração de solvente
|
|
AU2016319203A1
(en)
|
2015-09-10 |
2018-02-22 |
Grünenthal GmbH |
Protecting oral overdose with abuse deterrent immediate release formulations
|
|
CA3004363A1
(en)
|
2015-11-06 |
2017-05-11 |
Fraunhofer-Gesellschaft Zur Foerderung Der Angewandten Forschung E.V. |
Composition comprising a biocompatible and biodegradable polymer, nanocarries and a drug and methods of making and using the same
|